MIELOPOIESE ANORMAL TRANSITÓRIA EM RECÉM-NASCIDO COM SÍNDROME DE DOWN E CARDIOPATIA CONGÊNITA: RELATO DE CASO

Autor: GA Bernardino, ISC Miranda, CRL Souza, JCB Sobrinho, RS Caldas, JL Moreno, ACCD Morais, KLCMD Santos, EP Noronha, RAG Oliveira

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S371- (2024)

Objetivo: Relatar um caso de mielopoiese anormal transitória (MAT) em recém-nascido (RN) com síndrome de Down e malformações congênitas das câmaras e comunicações cardíacas. Material e métodos: Paciente do sexo masculino, RN, 01 dia de vid

Externí odkaz: https://doaj.org/article/059ea8d335c94ae591b0ec79222b5c1f

ESTRATÉGIA ALTERNATIVA PARA AVALIAR O PROGNOSTICO DE PACIENTES COM LEUCEMIA MIELOIDE AGUDA (LMA), EM UM SERVICO PÚBLICO, USANDO RECURSOS ACESSÍVEIS.

Autor: LFE Santana, LBD Santos, LV Oliveira, NA Leite, RML Borges, ET Granado, EP Noronha, MAS Araujo, MBV Lima

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S305- (2023)

Introdução: Os sistemas de classificação prognóstica para as Leucemia Mieloide Aguda (LMA), não são replicáveis, na maioria dos serviços públicos do Brasil, devido a dificuldade de acesso a exames citogenéticos e de avaliações moleculare

Externí odkaz: https://doaj.org/article/b28b94613e514f1ca0ce736c65b2dee0

IMPACTO DA RECLASSIFICAÇÃO DA EUROPEAN LEUKEMIANET 2022, NOS PACIENTES COM LEUCEMIA MIELOIDE: ESTUDO DE VIDA REAL, EM SERVIÇO PÚBLICO, REFERÊNCIA NA ASSISTÊNCIA ONCOHEMATOLOGICA

Autor: MBV Lima, ET Granado, MAS Araujo, EP Noronha, BM Ferraz, MIS Perdiz, DMS Ferreira, NA Leite, BG Silva

Publikováno v: Hematology, Transfusion and Cell Therapy. 44:S179

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40c4ccb1156ac46838baa040b7d9a9b3
https://doi.org/10.1016/j.htct.2022.09.302

Molecular characterization of V(D)J rearrangements in immature acute leukemias.

Autor: Vianna DT; Biological Molecular Laboratory, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil; Pediatric Hematology Service, Institute of Pediatrics and Childcare Martagão Gesteira (IPPMG), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. Electronic address: dvianna@inca.gov.br., Reis Monte-Mór BDC; Biological Molecular Laboratory, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Noronha EP; Cell Processing, Hematology and Hemotherapy Supervision Center of Maranhão (HEMOMAR), São Luís, Maranhão, Brazil., Gutiyama LM; Biological Molecular Laboratory, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., da Costa ES; Pediatrics Department, Faculty of Medicine, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., Pombo-de-Oliveira MS; Research Center, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Zalcberg I; Biological Molecular Laboratory, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.

Publikováno v: Leukemia research [Leuk Res] 2024 Aug; Vol. 143, pp. 107521. Date of Electronic Publication: 2024 Jun 03.

The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.

Autor: Mansur MB; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Paediatric Haematology-Oncology Program, Research Centre, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.; Division of Clinical Research, Research Centre, Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Furness CL; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Nakjang S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.; Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Enshaei A; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK., Alpar D; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Colman SM; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Minto L; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK., Irving J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK., Poole BV; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK., Noronha EP; Paediatric Haematology-Oncology Program, Research Centre, Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Savola S; Oncogenetics, MRC-Holland, Amsterdam, The Netherlands., Iqbal S; Centre for Haemato-Oncology, Barts Cancer Institute, London, UK., Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, London, UK., Pombo-de-Oliveira MS; Paediatric Haematology-Oncology Program, Research Centre, Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Ford TM; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Greaves MF; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., van Delft FW; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK.

Publikováno v: Cancer medicine [Cancer Med] 2021 Jul; Vol. 10 (14), pp. 4864-4873. Date of Electronic Publication: 2021 Jun 02.